How are these new synthetic products different from Nemacur?
The company that’s developing some new actives, Divergents Inc., has a neat approach. They were looking more at genome mapping, and then they started developing very target-specific compounds so they’re very selective and they only affect parasitic nematodes, as opposed to Nemacur, which targets anything with a nerve system. These will be very safe products and we’re finding them to be very effective. And then there are some that I can’t talk about at this time. But there are some new synthetic products we’ve had some good results with. How about on the biological side? There will be a product launched this year called EcoNem, which is distributed by Harrell’s. It’s a bacterium that’s specific for sting nematodes. So there’s no efficacy except for sting nematodes, which are a problem in much of Florida and throughout the sandy coastal plains. There’s the Bayer-purchased product I already talked about – they don’t have a name for it yet. It’s another bacteria. I’ve worked with it in the
